Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

We have designed and synthesized a novel series of alpha-amino cyclic boronates and incorporated them successfully in several acyclic templates at the P1 position. These compounds are inhibitors of the HCV NS3 serine protease, and structural studies show that they inhibit the NS3 protease by trapping the Ser-139 hydroxyl group in the active site. Synthetic methodologies and SARs of this series of compounds are described.

Knowledge Graph

Similar Paper

Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro
Bioorganic & Medicinal Chemistry 2015.0
Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety
Bioorganic & Medicinal Chemistry 2008.0
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups
Bioorganic & Medicinal Chemistry Letters 2012.0
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
Bioorganic & Medicinal Chemistry Letters 2014.0
Identification of Weak Points of Hepatitis C Virus NS3 Protease Inhibitors Using Surface Plasmon Resonance Biosensor-Based Interaction Kinetic Analysis and Genetic Variants
Journal of Medicinal Chemistry 2014.0
Achiral Pyrazinone-Based Inhibitors of the Hepatitis C Virus NS3 Protease and Drug-Resistant Variants with Elongated Substituents Directed Toward the S2 Pocket
Journal of Medicinal Chemistry 2014.0
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2–P1′ Region
ACS Medicinal Chemistry Letters 2014.0